AIT Bioscience, a bioanalytical contract research organization (CRO), has appointed Jeff Goddard, MBA, as chief executive officer and member of the AIT Bioscience Board of Directors. He succeeds Terri Pascarelli, MBA. During her time as CEO, Pascarelli has led the company to significant growth, including being named on Inc. 5000’s list of fastest growing companies in both 2015 and 2017.
 
Pascarelli has announced her retirement and will be transitioning the leadership of the company to the current vice president of business development, Jeff Goddard. “The Board of Directors and I are confident that Jeff will provide the necessary direction for the company’s continued success given how Jeff has already demonstrated his capabilities to meet sponsor needs. Since Jeff joined AIT Bioscience in early 2018, he has expanded the reach of our business development efforts and as a result of his leadership, AIT Bioscience is attracting a record number of new sponsors in 2019,” shared Pascarelli. 
 
Mr. Goddard brings extensive industry experience ranging from start-ups to Fortune 500 firms. He has held positions of increasing responsibility at companies including EPL Archives (acquired by VWR International in 2017), Biostorage Technologies (now Brooks Life Science), Gene Logic and Nalco Chemical Company.